Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data

BACKGROUND/AIMS: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid arthritis (RA), but safety concerns about malignancy remain. The aim of this study was to evaluate cancer risk in RA patients treated with TNF inhibitors (TNFi), based on Korean Nationwide Health Insu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Korean J Intern Med
Hauptverfasser: Jung, Seung Min, Kwok, Seung-Ki, Ju, Ji Hyeon, Park, Yong-Beom, Park, Sung-Hwan
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Association of Internal Medicine 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506746/
https://ncbi.nlm.nih.gov/pubmed/29172405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.374
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge